HTG Molecular Diagnostics, Inc.
HTGMQ
$0.0001
$0.000.00%
| 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -20.15M | -21.59M | -22.09M | -22.07M | -18.79M |
| Total Depreciation and Amortization | 487.70K | 587.10K | 640.00K | 699.20K | 708.80K |
| Total Amortization of Deferred Charges | 366.90K | 412.80K | 448.00K | 462.60K | 464.90K |
| Total Other Non-Cash Items | 2.62M | 2.33M | 1.59M | 1.89M | 174.30K |
| Change in Net Operating Assets | -157.30K | -143.10K | -361.00K | -383.10K | -648.60K |
| Cash from Operations | -16.83M | -18.41M | -19.77M | -19.40M | -18.09M |
| Capital Expenditure | -20.90K | -23.10K | -76.70K | -414.00K | -554.30K |
| Sale of Property, Plant, and Equipment | 104.00K | 104.00K | 104.00K | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 3.40M | 12.34M | 11.89M | 7.84M | 2.07M |
| Cash from Investing | 3.48M | 12.42M | 11.92M | 7.43M | 1.51M |
| Total Debt Issued | 822.90K | 822.90K | 822.90K | -- | -- |
| Total Debt Repaid | -7.18M | -7.79M | -6.77M | -3.27M | -2.02M |
| Issuance of Common Stock | 9.07M | 16.68M | 7.98M | 8.58M | 12.24M |
| Repurchase of Common Stock | -551.00K | -558.90K | -559.20K | -519.20K | -10.20K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -439.70K | -553.60K | -604.40K | -616.10K | -787.00K |
| Cash from Financing | 1.73M | 8.60M | 871.10K | 4.17M | 9.43M |
| Foreign Exchange rate Adjustments | 1.20K | -6.30K | -31.00K | -23.30K | -10.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -11.62M | 2.61M | -7.02M | -7.82M | -7.16M |
